trial · primary record
GEN3018
R/R AML
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 78 |
| Primary completion | 2030-04-20 |
| Primary endpoint | Part 1: Number of Participants with Dose-limiting Toxicities (DLTs) |
| Registry ID | NCT07384715 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:32:49.695Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07384715
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.